During the activities of the Fifth Annual Forum of the Egypt Healthcare Authority:
The Chairman of the Egypt Healthcare Authority, the CEO of the International Hospital Federation, and the General Manager of Roche witnessed the signing of a tripartite cooperation agreement between the Egypt Healthcare Authority, Roche Diagnostics, and Roche Pharmaceuticals.
Chairman of the Egypt Healthcare Authority: A strategic collaboration with Roche to enable digital pathology, enhance data governance to improve patient outcomes, and organize knowledge exchange programs with the best global hospitals.
Chairman of the Egypt Healthcare Authority: We are committed to developing healthcare services to achieve medical excellence in line with the latest global practices.
General Manager of Roche: The Egypt Healthcare Authority has achieved a remarkable transformation in healthcare services in Egypt, and we look forward to achieving further successes through our strategic partnership.
Dr. Ahmed El-Sebki, Chairman of the Egypt Healthcare Authority and Supervisor of the Universal Health Insurance Project, Dr. Ronald Lavatar, CEO of the International Hospital Federation, and Dr. Leila Kanaan, General Manager of Roche Diagnostics for Egypt and North Africa, witnessed the signing of a tripartite cooperation agreement between the Egypt Healthcare Authority, Roche Diagnostics, and Roche Pharmaceuticals during the activities of the Fifth Annual Forum of the Egypt Healthcare Authority.
The agreement was signed on behalf of the Egypt Healthcare Authority by Dr. Amir El-Tallawany, the Executive Director of the Authority, on behalf of Roche Diagnostics by Engineer Moataz Nassef, Executive Director of Roche Diagnostics for Egypt and North Africa, on behalf of Dr. Leila Kanaan, General Manager of the company. The agreement was also signed by Dr. Ziad Al-Ahowal, Head of Government Affairs, Health Policies, and Market Support for Roche Pharmaceuticals.
Dr. Ahmed El-Sebki, Chairman of the Egypt Healthcare Authority, confirmed that the signing of this agreement represents a pivotal step towards accelerating the implementation of modern technology in healthcare in Egypt, positively impacting the quality of healthcare services provided to citizens. He noted that enhancing cooperation with global partners such as Roche Diagnostics and Roche Pharmaceuticals reflects the Authority’s commitment to achieving excellence in healthcare services, in line with the strategic objectives of Egypt's Vision 2030.
El-Sebki further added that this tripartite partnership would significantly contribute to the development of digital pathology methodologies and enhance data governance, supporting the Authority's ability to make accurate health decisions based on the latest global technologies, reinforcing Egypt's position as a leading destination for healthcare services regionally and internationally.
On her part, Dr. Leila Kanaan, General Manager of Roche Diagnostics for Egypt and North Africa, expressed her pleasure at collaborating with the Egypt Healthcare Authority on this strategic initiative. She confirmed that Roche is committed to providing the latest technological solutions to support the development of Egypt’s healthcare system. She pointed out that the agreement reflects a shared vision to achieve a qualitative transformation in the healthcare sector by fostering innovation and relying on technology to improve patient health outcomes.
It is worth noting that the Fifth Annual Forum of the Egypt Healthcare Authority was held under the patronage of Professor Dr. Mostafa Madbouly, the Prime Minister of Egypt, under the theme "Towards Global Excellence in Healthcare Services," in the New Administrative Capital.
